BI-9321

N/A

Report date: 2023/03/13 10:45:41
NME

Base Information

Drug NameBI-9321
Drug Alias NameBI-9321
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear Receptor Binding SET Domain Protein 3 inhibitors
TargetsNuclear Receptor Binding SET Domain Protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A